Findings

What do systematic reviews say?

8 questions · 8 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 3 · 37.5%GRADE not reported 1 · 12.5%Very low 0 · 0%Low 4 · 50%Moderate 0 · 0%High 0 · 0%

Extensive tests vs tests at the physician's discretion

All‐cause mortality1 · people with unprovoked VTE

The review found no eligible studies for this question.

1 finding from 1 review

Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with… 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Extensive tests vs tests at the physician's discretion

Cancer‐related mortality at maximal · people with unprovoked VTE

Extensive tests showed no clear difference in cancer‐related mortality2 compared with tests at the physician's discretion (low certainty).

1 finding from 1 review

Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with… 2021 · Cochrane Headline outcomes only
OR 0.49 [0.15, 1.67]
2 studies · 396 participants
Low

Extensive tests vs tests at the physician's discretion

VTE‐related mortality4 · people with unprovoked VTE

The review found no eligible studies for this question.

1 finding from 1 review

Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with… 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Extensive tests vs tests at the physician's discretion

VTE‐related morbidity5 · people with unprovoked VTE

The review found no eligible studies for this question.

1 finding from 1 review

Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with… 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Extensive tests vs tests at the physician's discretion

Stage at diagnosis (early-stage detection) · people with unprovoked VTE

Extensive tests may leads to higher stage of cancer ‐ early6 compared with tests at the physician's discretion (low certainty).

1 finding from 1 review

Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with… 2021 · Cochrane Headline outcomes only
OR 5 [1.05, 23.76]
1 study · 201 participants
Low

Extensive tests vs tests at the physician's discretion

Stage of cancer ‐ advanced · people with unprovoked VTE

Extensive tests showed no clear difference in stage of cancer ‐ advanced8 compared with tests at the physician's discretion (low certainty).

1 finding from 1 review

Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with… 2021 · Cochrane Headline outcomes only
OR 0.25 [0.03, 2.28]
1 study · 201 participants
Low

Extensive tests vs tests at the physician's discretion

Time to cancer diagnosis7 · people with unprovoked VTE

1 finding from 1 review

Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with… 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 201 participants
GRADE not reported

Extensive tests vs tests at the physician's discretion

Frequency of an underlying cancer diagnosis8 · people with unprovoked VTE

Extensive tests showed no clear difference in frequency of underlying cancer diagnosis10 compared with tests at the physician's discretion (low certainty).

1 finding from 1 review

Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with… 2021 · Cochrane Headline outcomes only
OR 1.32 [0.59, 2.93]
2 studies · 396 participants
Low